Somerset Trust CO Amgen Inc Transaction History

Somerset Trust CO

  • $256 Million
  • Q4 2024

A detailed history of Somerset Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Somerset Trust CO holds 19,183 shares of AMGN stock, worth $6.06 Million. This represents 1.96% of its overall portfolio holdings.

Number of Shares
19,183
Previous 18,562 3.35%
Holding current value
$6.06 Million
Previous $5.98 Million 16.4%
% of portfolio
1.96%
Previous 2.29%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 15, 2025
BUY
$258.78 - $328.31 $160,702 - $203,880
621 Added 3.35%
19,183 $5 Million
Q3 2024

Oct 08, 2024
SELL
$309.38 - $337.38 $34,959 - $38,123
-113 Reduced 0.61%
18,562 $5.98 Million
Q2 2024

Jul 09, 2024
BUY
$262.75 - $319.31 $23,647 - $28,737
90 Added 0.48%
18,675 $5.84 Million
Q1 2024

Apr 05, 2024
BUY
$268.87 - $324.56 $110,774 - $133,718
412 Added 2.27%
18,585 $5.28 Million
Q4 2023

Jan 08, 2024
SELL
$255.7 - $288.46 $224,504 - $253,267
-878 Reduced 4.61%
18,173 $5.23 Million
Q3 2023

Oct 17, 2023
SELL
$218.65 - $271.46 $22,083 - $27,417
-101 Reduced 0.53%
19,051 $5.12 Million
Q2 2023

Jul 07, 2023
SELL
$214.27 - $253.37 $132,418 - $156,582
-618 Reduced 3.13%
19,152 $4.25 Million
Q1 2023

Apr 05, 2023
SELL
$225.79 - $275.2 $58,705 - $71,552
-260 Reduced 1.3%
19,770 $4.78 Million
Q4 2022

Jan 03, 2023
SELL
$229.03 - $291.01 $8,016 - $10,185
-35 Reduced 0.17%
20,030 $5.26 Million
Q3 2022

Oct 03, 2022
BUY
$224.46 - $253.15 $55,890 - $63,034
249 Added 1.26%
20,065 $4.52 Million
Q2 2022

Jul 06, 2022
BUY
$230.71 - $256.74 $36,913 - $41,078
160 Added 0.81%
19,816 $4.82 Million
Q1 2022

Apr 05, 2022
SELL
$219.27 - $242.57 $19,953 - $22,073
-91 Reduced 0.46%
19,656 $4.75 Million
Q4 2021

Jan 07, 2022
BUY
$198.88 - $227.6 $28,638 - $32,774
144 Added 0.73%
19,747 $4.44 Million
Q3 2021

Oct 07, 2021
SELL
$212.27 - $248.7 $40,331 - $47,253
-190 Reduced 0.96%
19,603 $4.17 Million
Q2 2021

Jul 06, 2021
BUY
$233.58 - $259.14 $13,314 - $14,770
57 Added 0.29%
19,793 $4.82 Million
Q1 2021

Apr 07, 2021
BUY
$221.91 - $258.6 $72,564 - $84,562
327 Added 1.68%
19,736 $4.91 Million
Q4 2020

Jan 25, 2021
SELL
$216.38 - $257.67 $16,012 - $19,067
-74 Reduced 0.38%
19,409 $4.46 Million
Q3 2020

Oct 15, 2020
BUY
$234.65 - $260.95 $78,842 - $87,679
336 Added 1.75%
19,483 $4.95 Million
Q2 2020

Jul 17, 2020
BUY
$197.81 - $242.74 $100,091 - $122,826
506 Added 2.71%
19,147 $4.52 Million
Q1 2020

Apr 20, 2020
BUY
$182.24 - $241.7 $70,344 - $93,296
386 Added 2.11%
18,641 $3.78 Million
Q4 2019

Jan 17, 2020
BUY
$189.21 - $243.2 $18,164 - $23,347
96 Added 0.53%
18,255 $4.4 Million
Q3 2019

Oct 25, 2019
SELL
$174.11 - $208.62 $83,921 - $100,554
-482 Reduced 2.59%
18,159 $3.51 Million
Q2 2019

Jul 31, 2019
BUY
$166.7 - $195.41 $8,335 - $9,770
50 Added 0.27%
18,641 $3.44 Million
Q1 2019

Apr 09, 2019
BUY
$180.87 - $203.88 $35,993 - $40,572
199 Added 1.08%
18,591 $3.53 Million
Q4 2018

Jan 22, 2019
BUY
$178.4 - $208.25 $45,135 - $52,687
253 Added 1.39%
18,392 $3.58 Million
Q3 2018

Oct 15, 2018
BUY
$185.29 - $208.89 $14,823 - $16,711
80 Added 0.44%
18,139 $3.76 Million
Q2 2018

Jul 19, 2018
SELL
$166.05 - $186.51 $69,408 - $77,961
-418 Reduced 2.26%
18,059 $3.33 Million
Q1 2018

Apr 13, 2018
SELL
$169.43 - $198.0 $3,219 - $3,762
-19 Reduced 0.1%
18,477 $3.15 Million
Q4 2017

Jan 17, 2018
SELL
$168.79 - $188.59 $2,531 - $2,828
-15 Reduced 0.08%
18,496 $3.22 Million
Q3 2017

Oct 13, 2017
BUY
$167.29 - $191.0 $3.1 Million - $3.54 Million
18,511
18,511 $3.45 Million

Others Institutions Holding AMGN

# of Institutions
3,182
Shares Held
419M
Call Options Held
8.25M
Put Options Held
6.39M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Somerset Trust CO Portfolio

Follow Somerset Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerset Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Somerset Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email